【结 构 式】 |
【分子编号】67466 【品名】1-((8R,13R,14R)-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone 【CA登记号】 |
【 分 子 式 】C22H30O4 【 分 子 量 】358.4778 【元素组成】C 73.71% H 8.44% O 17.85% |
与该中间体有关的原料药合成路线共 2 条
合成路线1
该中间体在本合成路线中的序号: (V)
【1】 Dancsi L, Visky G, Tuba Z, et al.2007.Industrial process for the synthesis of 17α-acetoxy-11β-[4-(N,N-dimethylamino) Phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process. WO 2007144674 A1. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 67466 | 1-((8R,13R,14R)-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone | C22H30O4 | 详情 | 详情 | |
(I) | 30502 | 3,3-Ethylenedioxyestra-5(10),9(11)-dien-17-one | 5571-36-8 | C20H26O3 | 详情 | 详情 |
(II) | 67463 | (8R,13R,14R,17S)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol | C22H28O3 | 详情 | 详情 | |
(III) | 67464 | (8R,13R,14R)-13-methyl-17-(2-(phenylsulfinyl)vinylidene)-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane] | C28H32O3S | 详情 | 详情 | |
(IV) | 67465 | (8R,13R,14R)-17-(1-methoxyvinyl)-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol | C23H32O4 | 详情 | 详情 | |
(VI) | 40868 | C24H34O5 | 详情 | 详情 | ||
(VII) | 40869 | C24H34O6 | 详情 | 详情 | ||
(VIII) | 40870 | C32H45NO6 | 详情 | 详情 | ||
(IX) | 40871 | (13S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | C28H35NO3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(III)
【1】 Kim H, Pemmaraju N, Simmons Anne-Marie.2004.Process for the preparation of 17α-acetoxy-11β-[4-(N,N-dimethylamino) phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process. WO 2004078709 A2. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 40867 | (13S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | 14340-01-3 | C20H26O3 | 详情 | 详情 |
(II) | 67474 | (13R,17S)-17-acetyl-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate | C22H28O4 | 详情 | 详情 | |
(III) | 67466 | 1-((8R,13R,14R)-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone | C22H30O4 | 详情 | 详情 | |
(IV) | 67475 | 1-((5S,10S,13R,17S)-17-hydroxy-13- methyl-1,2,4,6,7,8,12,13,14,15,16,17- dodecahydrospiro[5,10-epoxycyclopenta[a] phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone | C22H30O5 | 详情 | 详情 | |
(V) | 67476 | 1-((5S,13R,17S)-11-(4-(dimethylamino) phenyl)-5,17-dihydroxy-13-methyl- 1,2,4,5,6,7,8,11,12,13,14,15,16,17- tetradecahydrospiro[cyclopenta[a]phenanthrene-3,2'- [1,3]dioxolan]-17-yl)ethanone | C30H41NO5 | 详情 | 详情 |
Extended Information